Ana Luisa Silva
Sanofi
Appearances
DateSeptember 19, 2023TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative AssessmentsSpeakers
Seagen Inc.DIGEMID-General Directorate of Medicines, Supplies and DrugsGilead Sciences, Inc.SanofiSanofiDIGEMID-General Directorate of Medicines, Supplies and DrugsThis product is only available to members of the following groups:
- Members
DateSeptember 19, 2023TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative AssessmentsSpeakers
Seagen Inc.DIGEMID-General Directorate of Medicines, Supplies and DrugsGilead Sciences, Inc.SanofiSanofiDIGEMID-General Directorate of Medicines, Supplies and DrugsThis product is only available to members of the following groups:
- Members
